Application of Healthcare ‘Big Data’ in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN)
Jenni Ilomäki, J. Simon Bell, Adrienne Y.L. Chan, Anna Maija Tolppanen, Hao Luo, Li Wei, Edward Chia Cheng Lai, Ju Young Shin, Giorgia De Paoli, Romin Pajouheshnia, Frederick K. Ho, Lorenna Reynolds, Kui Kai Lau, Stephen Crystal, Wallis C.Y. Lau, Kenneth K.C. Man, Ruth Brauer, Esther W. Chan, Chin Yao Shen, Ju Hwan Kim, Terry Y.S. Lum, Sirpa Hartikainen, Marjaana Koponen, Evelien Rooke, Marloes Bazelier, Olaf Klungel, Soko Setoguchi, Jill P. Pell, Sharon Cook, Ian C.K. Wong
09/01/2020
Abstract: Neurological and psychiatric (mental health) disorders have a large impact on health burden globally. Cognitive disorders (including dementia) and stroke are leading causes of disability. Mental health disorders, including depression, contribute up to one-third of total years lived with disability. The Neurological and mental health Global Epidemiology Network (NeuroGEN) is an international multi-database network that harnesses administrative and electronic medical records from Australia, Asia, Europe and North America.